Back to search results
NCT05338151

Promoting Alcohol Treatment Engagement Post-hospitalization

Active, Not Recruiting
NAAges 18+InterventionalTreatment
Yale University
~450 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Brief Negotiated Interview (BNI)BNI+facilitated provision of MAUDBrief Negotiated Interview BNI+facilitated provision of MAUD+CBT4CBT

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The primary outcome will be the percentage of participants engaged in AUD Treatment at the 34-day post hospital discharge timepoint, defined as any self-reported AUD treatment service assessed on the AUD Treatment Assessment.
Measured over Day 34 post hospital diacharge

Conditions

Alcohol Use Disorder

Explore related trials

Alcohol use disorder

Where it's being run

1 sites across 1 states
Connecticut1

Study leadership

  • E. Jennifer Edelman, MD · PRINCIPAL_INVESTIGATOR · Yale University
  • Brian Kiluk, PhD · PRINCIPAL_INVESTIGATOR · Yale University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

hospitalized at Yale New Haven Hospital (YNHH)
meet Diagnostic and Statistical Manual (DSM-5) criteria for a moderate to severe AUD (regardless of primary reason for hospitalization) consistent with clinical guidelines for MAUD initiation
\>1 heavy drinking day by TLFB in 30 days prior to hospitalization
willing to consider MAUD
willing and able to be contacted for follow-up
provide written informed consent

Exclusion

have been engaged in formal AUD treatment in the past 30 days (i.e., excluding mutual help groups, such as Alcoholics Anonymous)
meet DSM-5 criteria for untreated moderate to severe opioid use disorder
self-reported or urine testing confirming pregnancy, nursing, or trying to conceive
life-threatening or unstable medical, surgical, or psychiatric condition that prohibits study participation
inability to provide \>1 collateral contact for a friend or family member
anticipate being unable to return for follow-up assessments for any reason, such as travel, incarceration, planned procedure
inability to understand English or Spanish.

What this trial measures

  • The primary outcome will be the percentage of participants engaged in AUD Treatment at the 34-day post hospital discharge timepoint, defined as any self-reported AUD treatment service assessed on the AUD Treatment Assessment.Day 34 post hospital diacharge

    AUD Treatment Engagement Assessment is a self-report used to assess if participants have participated in different types of treatment engagement for alcohol use over 34 days. That data is verified by an outside source.